SWM
CAPR icon

Selective Wealth Management’s Capricor Therapeutics CAPR Stock Holding History

Selective Wealth Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-213,494
Closed -$732K – 764
2022
Q1 		$732K Buy
+213,494
New +$842K 0.27% 47

Other funds holding CAPR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Selective Wealth Management's CAPR Position: Q2 2022 in Review

Selective Wealth Management sold out of Capricor Therapeutics (CAPR) in Q2 2022, closing a stake of 213,494 shares — an estimated $732K sold.

Selective Wealth Management first reported a position in CAPR in Q1 2022 and held it in 1 quarter. The position peaked at $732K in Q1 2022. 29 funds tracked by Wall St. Rank hold CAPR as of Q2 2022.

  • Selective Wealth Management reported no remaining Capricor Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Selective Wealth Management sold 213,494 Capricor Therapeutics shares in Q2 2022, an estimated $732K.
  • Selective Wealth Management first reported a position in Capricor Therapeutics in Q1 2022 and held it in 1 quarter.
  • Selective Wealth Management's Capricor Therapeutics position peaked at $732K in Q1 2022.
  • 29 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2022.

Based on Selective Wealth Management's 13F filing for Q2 2022, filed 28 Jul 2022.